SCOTUS asks for SG’s view on enablement in antibody dispute

19-04-2022

Muireann Bolger

SCOTUS asks for SG’s view on enablement in antibody dispute

Steve Heap / Shutterstock.com

The US Supreme Court has asked the Solicitor General to wade in on a case centring on the legal concept of enablement that is the crux of an antibody patent dispute between Amgen and Sanofi.


SCOTUS, SG, enablement, Amgen, Sanofi, antibody dispute

LSIPR